A roadmap for translational cancer glycoimmunology at single cell resolution

Cancer cells can evade immune responses by exploiting inhibitory immune checkpoints. Immune checkpoint inhibitor (ICI) therapies based on anti-CTLA-4 and anti-PD-1/PD-L1 antibodies have been extensively explored over the recent years to unleash otherwise compromised anti-cancer immune responses. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Peixoto, Andreia, Miranda, Andreia, Santos, Lúcio Lara, Ferreira, José Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013178/
https://www.ncbi.nlm.nih.gov/pubmed/35428302
http://dx.doi.org/10.1186/s13046-022-02335-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013178/
https://www.ncbi.nlm.nih.gov/pubmed/35428302
http://dx.doi.org/10.1186/s13046-022-02335-z

Ejemplares similares